2019
The metabolic profile of essential oils and assessment of anti-urease activity by ESI-mass spectrometry of Salvia officinalis L.
HASSAN, STS.; Emil ŠVAJDLENKA; KRR. RENGASAMY; R. MELICHARKOVA; SK. PANDIAN et al.Základní údaje
Originální název
The metabolic profile of essential oils and assessment of anti-urease activity by ESI-mass spectrometry of Salvia officinalis L.
Autoři
HASSAN, STS.; Emil ŠVAJDLENKA; KRR. RENGASAMY; R. MELICHARKOVA a SK. PANDIAN
Vydání
SOUTH AFRICAN JOURNAL OF BOTANY, AMSTERDAM, ELSEVIER SCIENCE BV, 2019, 0254-6299
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.792
Označené pro přenos do RIV
Ne
UT WoS
Klíčová slova anglicky
Anti-urease activity; Antibacterial agent; Chemotype; Essential oils composition; Phenolic content; Salvia officinalis L.
Změněno: 24. 2. 2021 14:18, PharmDr. Jitka Michlíčková
Anotace
V originále
For decades, the therapeutic benefits of medicinal plants and their biologically active constituents have been well documented. In this study, the metabolic profile of Egyptian Salvia officinalis essential oils using Gas Chromatography (GC) and Gas Chromatography-Mass Spectrometry (GC-MS), total phenolic content (TPC) and anti-enzymatic properties of aqueous extract of S. officinalis (AESO) against jack bean urease (JBU) by an Electrospray Ionization-Mass Spectrometry (ESI-MS) were investigated. The results revealed that the primary metabolites detected in Salvia essential oils were 1,8-cineole (15.4%), oxygenated sesquiterpene viridiflorol (7.1%), nonacosane (3.1%), camphor (3.0%), and pentacosane (2.4%). The TPC content was determined to be 37.1 mg GAE/g dry plant material, while AESO exerted for the first time, anti-JBU with an IC50 value of 1.65 mg/mL. This study presents phenolic-rich AESO as a promising curative agent in the development of urease inhibitors useful to treat diseases induced by urease-producing pathogens. (c) 2018 SAAB. Published by Elsevier B.V. All rights reserved.